This list is an analysis based on recent market events. It's not an investment recommendation.
TiumBio Co., Ltd., a drug discovery company, researches and develops therapeutics for patients with unaddressed rare diseases. The company's products pipeline includes chemical entity-based drugs and biopharmaceuticals comprising NCE401, NCE403, NCE406, and NBP604. It has a collaboration agreement with Oncodesign Société Anonyme for the research and development of fibrosis drug candidates. The company was founded in 2016 and is based in Seongnam-si, South Korea.
FAQs
What is TiumBio. stock price today?▼
The current price of 321550.KQ is ₩3,645 KRW — it has decreased by -0.27% in the past 24 hours. Watch TiumBio. stock price performance more closely on the chart.
What is TiumBio. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange TiumBio. stocks are traded under the ticker 321550.KQ.
Is TiumBio. stock price growing?▼
321550.KQ stock has fallen by -4.95% compared to the previous week, the month change is a -19.45% fall, over the last year TiumBio. has showed a -56.4% decrease.
What is TiumBio. market cap?▼
Today TiumBio. has the market capitalization of 107.17B
What is TiumBio. revenue for the last year?▼
TiumBio. revenue for the last year amounts to 2.95B KRW.
What is TiumBio. net income for the last year?▼
321550.KQ net income for the last year is -5.41B KRW.
How many employees does TiumBio. have?▼
As of November 4, 2026, the company has 68 employees.
In which sector is TiumBio. located?▼
TiumBio. operates in the Energy sector.
When did TiumBio. complete a stock split?▼
TiumBio. has not had any recent stock splits.
Where is TiumBio. headquartered?▼
TiumBio. is headquartered in Seongnam-si, South Korea.